taxifolin has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, BL; Wang, W; Xu, CG; Zhou, XJ | 1 |
| Chen, Y; Cui, Y; Guo, H; Guo, Y; Shan, T; Wu, D; Xu, D; Zhang, F; Zhang, X; Zhou, H | 1 |
2 other study(ies) available for taxifolin and Cirrhosis
| Article | Year |
|---|---|
Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Topics: Animals; Fibrosis; Hydrogen Peroxide; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Phosphorylation; Protective Agents; Quercetin; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction | 2020 |
Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Electrocardiography; Fibrosis; Mice; Myocytes, Cardiac; Oxidative Stress; Peptidyl-Dipeptidase A; Quercetin; Reactive Oxygen Species; Signal Transduction | 2015 |